Netflix Acquires InterPositive

Netflix Acquires InterPositive after buying Ben Affleck's AI filmmaking firm on March 5, 2026 and signaled capital discipline favoring targeted tech M&A.

March 05, 2026·1 min read
View all news articles
Flat filled vector of a film reel fused with a compact server to evoke Netflix Acquires InterPositive and AI film tools.

KEY TAKEAWAYS

  • Netflix acquired InterPositive and will integrate its team of fewer than 20 people.
  • Ben Affleck will join as a senior adviser; tools aim to apply AI to post-production and special effects.
  • The purchase followed Netflix's Feb. 26, 2026 decision not to raise its Warner Bros. bid, signaling capital discipline.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Netflix said in a press release on March 5, 2026, that it acquired InterPositive, an AI filmmaking company founded by Ben Affleck in 2022. The entire InterPositive team will join Netflix, with Affleck serving as a senior adviser. The move aligns with Netflix’s AI strategy to enhance special effects in its original productions.

Deal Terms and Integration

InterPositive employed fewer than 20 people. Netflix did not disclose financial terms for the acquisition. The company said the full InterPositive team will integrate into Netflix, with Affleck joining as a senior adviser.

Technology and Strategic Context

InterPositive develops AI tools for post-production tasks such as correcting continuity, adjusting lighting, and enhancing environments. Its systems, trained on proprietary production footage, emphasize visual logic, editorial consistency, and cinematic rules while including safeguards to preserve creative intent.

Netflix described the acquisition as part of its broader AI strategy to apply advanced technology to special effects in originals. Elizabeth Stone, Netflix’s chief product and technology officer, said, "Our approach to AI has always been focused on meaningfully serving the needs of the creative community and our members."

The acquisition follows Netflix’s decision on Feb. 26, 2026, to decline raising its offer for Warner Bros. after a superior proposal from Paramount Skydance. Netflix’s co-chief executives framed that decision as financial discipline, signaling a preference for targeted technology investments over larger takeover spending.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Netflix Earnings Send NFLX Stock Lower

Netflix Earnings Send NFLX Stock Lower

Netflix earnings for Q1 2026 beat forecasts but weak Q2 guidance and Reed Hastings' planned June exit pushed shares lower in after-hours trading.

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos limited Glasswing rollout to banks prompted regulator scrutiny and raised cyber and operational risk, complicating bank positioning.

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines liquidation risk rises as jet fuel may exceed year-end cash, prompting creditors' doubts and forcing traders to reassess credit exposure.

AMD Stock Rises on Bernstein Raise and AI Demand

AMD Stock Rises on Bernstein Raise and AI Demand

AMD stock rose after Bernstein raised its 12-month target as record EPYC and MI300 data-center demand boosted flows ahead of May 5 Q1 2026 earnings.

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 went general; pricing stayed unchanged and Mythos stayed gated, a setup that could shift cloud AI costs and investor positioning.

Abbott Earnings Beat After Exact Sciences Deal

Abbott Earnings Beat After Exact Sciences Deal

Abbott earnings posted revenue and adjusted-profit beats but narrowed FY EPS guidance after the Exact Sciences acquisition, likely pressuring shares.